Brightsurf Science News & Current Events

September 17, 2000
Chemical found in computer can cause allergy, sickness
New research suggests that emissions from the plastic of your computer's video monitor may be affecting your health, according to a Swedish study presented in the current (Sept.

Massive new research effort will map inner workings of cells - San Francisco VA Medical Center chosen to host core laboratory
A new $50 million dollar research program launched this month will begin the daunting task of mapping out the thousands of molecular interactions that cells use in responding to their environment.

New report looks at genome boom in microbiology
Large-scale DNA sequencing of microbes will lead to far reaching advances in medicine, agriculture, and ecology, a new report from the American Academy of Microbiology says.

Avandia positively impacts on factors linked with insulin resistance
New studies presented at the annual conference of the European Association for the Study of Diabetes (EASD) support the suggestion that AvandiaTM (rosiglitazone) improves fat distribution and endothelial function through its impact on insulin resistance, a fundamental cause of type 2 diabetes.

NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
NIH has awarded a six-month $290,000 SBIR grant to MetaPhore Pharmaceuticals to study potential new treatments for managing both acute and chronic pain using the company's patented metal-based compounds that mimic superoxide dismutase(SOD) -- the body's primary defense mechanism against oxidative damage from the free radicals.

Avandia provides new combination option for patients with inadequately controlled type 2 diabetes
AvandiaTM (rosiglitazone), SmithKline Beecham's oral anti- diabetic agent recently approved in Europe, provides a new combination option for patients with inadequately controlled type 2 diabetes.

Estimated costs of treating abnormal fat distribution and metabolic abnormalities in HIV-infected individuals
The first-year costs to manage a single symptom of an increasingly common complication associated with HIV/AIDS therapy ('lipodystrophy syndrome')could range from $410 to $7,369 per patient, according to a pharmacoeconomic modeling study presented at the 40th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

Nurse visits reduce child abuse and neglect
In the longest study on record, Cornell University researchers and colleagues report that nurse home visits to low-income, unmarried women during pregnancy and the first two years of their babies' lives helped reduce child abuse by up to 80 percent.

NIDA clinical toolbox provides the latest information about drug treatment strategies
The National Institute on Drug Abuse is sending its new

Olive oil seems to protect against bowel cancer
Olive oil seems to protect against bowel cancer, suggests research involving 28 countries in the Journal of Epidemiology and Community Health.

Study compares efficacy and adherence to triple nucleoside therapy Ziagen + Combivir with protease inhibitor plus Combivir regimens in therapy-nave
An interim analysis of an ongoing study comparing efficacy, safety, and patient adherence to the triple nucleoside regimen of Ziagen® (abacavir sulfate) plus Combivir® (lamivudine/zidovudine) with a triple-drug regimen containing a protease inhibitor (PI) as first-line antiretroviral therapy (ART) was presented here today at the 40th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

Long working days with too few hours' sleep slow responses as much as alcohol
After 17 to 19 hours of staying awake -- a normal working day for many people -- reaction times are up to 50 percent slower than they are after drinking alcohol, shows research in Occupational and Environmental Medicine.

Evolution of genetic variations that protect against Alzheimer's and cardiovascular diseases
In The American Journal of Human Genetics, researchers present evidence that human evolution has led to a decrease in the prevalence of certain genetic variations that are associated with an increased risk for Alzheimer's disease and cardiovascular disease.

NSF awards $89 million to 13 U.S. cities to improve urban math & science teaching
The National Science Foundation (NSF) has recommended 13 U.S. cities to receive awards totaling $89 million over five years to improve K-12 science, mathematics and technology education in urban school districts.

Urgent action required to cut the cost of type 2 diabetes
Urgent action to achieve sustained glycaemic control and reduce the risk of complications is needed to contain the escalating cost of type 2 diabetes, according to new data released at the annual conference of the European Association for the Study of Diabetes (EASD).

Inheritable gene modification research should not proceed on humans without standards and oversight, AAAS report says
Modifying human genes that can be transmitted to offspring is neither safe nor responsible at this time, according to a special report of the American Association for the Advancement of Science (AAAS).

Anti-acne drug that causes serious birth defects must be more strictly regulated, March of Dimes says
Warning that too many pregnant women are being exposed to Accutane (isotretinoin), which can cause severe birth defects, the March of Dimes today told the Food and Drug Administration at a public meeting that the drug must be regulated by the same rigorous system used for thalidomide.

Mutations in the ABCR gene are an overwhelming cause of inherited vision loss
In The American Journal of Human Genetics, two groups report evidence that mutations in the ABCR gene play a very important role in vision loss.The implication that a single gene is responsible for a wide range of retinal disorders makes it plausible that a single therapy could alleviate or prevent retinal degeneration and vision loss in a substantial number of affected or at-risk individuals.

Communicator Prize 2000 goes to Albrecht Beutelspacher
Albrecht Beutelspacher is the first winner of the newly created Communicator Prize.

America's dirty little secret: second handwashing survey reveals Americans still don't get it
While 95 percent of men and women surveyed say they wash their hands after using a public restroom, only 67 percent of people actually do wash before leaving the restroom, according to the results of a new survey and observational study conducted for the American Society of Microbiology.

Nutrient in cruciferous vegetables protects against lung cancer in study of 18,244 Chinese; benefit depends on genetic factor
A class of nutrients, isothiocyanates, found only in cruciferous vegetables - broccoli, cauliflower, cabbage, watercress, bok choy, among others - was protective against lung cancer in the study of a sample of 18,244 males, 45-64 years old in Shanghai, China.

Persistent smoking reduces full benefit of angioplasty
People who never smoked or quit smoking after undergoing balloon angioplasty and other procedures to open obstructed heart arteries had substantially greater improvements in health-related quality of life both six months and one year later compared to people who continued to smoke, according to researchers at Beth Israel Deaconess Medical Center in Boston.

Is everything you know about love and sex wrong?
When it comes to love and sex, one size definitely doesn't fit all.

Factive® faster than Biaxin® in eradicating the leading cause of airway infections in patients with chronic bronchitis
SmithKline Beecham's (NYSE: SBH) investigational antibiotic Factive® (gemifloxacin mesylate) eradicated the bacterium, H. influenzae, after one day of treatment in airway infections in patients with chronic bronchitis, according to data presented at the 40th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) in Toronto.

Avandia targets both fundamental causes of type 2 diabetes - offering new hope for delaying disease progression
Addressing insulin resistance and declining beta-cell function may be the key to delaying the progression of type 2 diabetes, according to experts at the annual conference of the European Association for the Study of Diabetes (EASD).

NSF engineering centers will advance microsystem and sensing technologies
The National Science Foundation (NSF) has launched two new Engineering Research Centers (ERCs) at the University of Michigan at Ann Arbor and Northeastern University in Boston, Mass., with an estimated NSF investment of up to $32 million over five years.

University of Pittsburgh Medical Center begins study to evaluate bypass surgery without general anesthesia
The University of Pittsburgh has launched a study to determine if there are advantages of performing minimally invasive direct coronary bypass surgery without general anesthesia.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.